nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of forward and inverse planned conformal, multi segment and intensity modulated radiotherapy for the treatment of prostate and pelvic nodes
|
Vaarkamp, Jaap |
|
2004 |
73 |
1 |
p. 65-72 8 p. |
artikel |
2 |
Anatomy based inverse planning in HDR prostate brachytherapy
|
Kolkman-Deurloo, Inger-Karine K. |
|
2004 |
73 |
1 |
p. 73-77 5 p. |
artikel |
3 |
Bilateral leg amputation following chemoradiation for squamous carcinoma of the anus
|
Evans, Tamasin K.A. |
|
2004 |
73 |
1 |
p. 110-111 2 p. |
artikel |
4 |
Calendar of Events
|
|
|
2004 |
73 |
1 |
p. 113-114 2 p. |
artikel |
5 |
Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy
|
Wust, Peter |
|
2004 |
73 |
1 |
p. 39-48 10 p. |
artikel |
6 |
Comment on: ‘Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients’ Radiother Oncol 70: 261–264, 2004 by Dr Rades et al.
|
Cengiz, Mustafa |
|
2004 |
73 |
1 |
p. 109- 1 p. |
artikel |
7 |
Contents
|
|
|
2004 |
73 |
1 |
p. v- 1 p. |
artikel |
8 |
Dosimetric verification of a commercial collapsed cone algorithm in simulated clinical situations
|
Nisbet, Andrew |
|
2004 |
73 |
1 |
p. 79-88 10 p. |
artikel |
9 |
EDITORIAL BOARD
|
|
|
2004 |
73 |
1 |
p. ii- 1 p. |
artikel |
10 |
Editorial Board
|
|
|
2004 |
73 |
1 |
p. iv- 1 p. |
artikel |
11 |
Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy
|
Williams, Scott G. |
|
2004 |
73 |
1 |
p. 33-38 6 p. |
artikel |
12 |
Feasibility study of entrance in vivo dose measurements with mailed thermoluminescence detectors
|
Swinnen, Ans |
|
2004 |
73 |
1 |
p. 89-96 8 p. |
artikel |
13 |
Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101)
|
Rancati, T. |
|
2004 |
73 |
1 |
p. 21-32 12 p. |
artikel |
14 |
Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial
|
Koper, Peter C. |
|
2004 |
73 |
1 |
p. 1-9 9 p. |
artikel |
15 |
Important ESTRO dates
|
|
|
2004 |
73 |
1 |
p. 112- 1 p. |
artikel |
16 |
Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA)
|
Zubizarreta, Eduardo H. |
|
2004 |
73 |
1 |
p. 97-100 4 p. |
artikel |
17 |
Performing daily prostate targeting with a standard V-EPID and an automated radio-opaque marker detection algorithm
|
Beaulieu, Luc |
|
2004 |
73 |
1 |
p. 61-64 4 p. |
artikel |
18 |
Quality assurance of the 22961 EORTC trial. A phase III study of the optimal combination of hormonal adjuvant treatment by LHRH analogue and radiation therapy for the management of locally advanced prostate cancer: the dummy run
|
Kouloulias, Vassilis E. |
|
2004 |
73 |
1 |
p. 11-20 10 p. |
artikel |
19 |
Quality of permanent prostate implants using automated delivery with seedSelectron™ versus manual insertion of RAPID Strands™
|
Van Gellekom, Marion P.R. |
|
2004 |
73 |
1 |
p. 49-56 8 p. |
artikel |
20 |
Reply to the letter by M. Cengiz et al.
|
Rades, Dirk |
|
2004 |
73 |
1 |
p. 109-110 2 p. |
artikel |
21 |
Stable overall referral rates of primary radiotherapy for newly diagnosed cancer patients in the ageing population of South-Eastern Netherlands, 1975–1998
|
Lybeert, Marnix L.M. |
|
2004 |
73 |
1 |
p. 101-108 8 p. |
artikel |
22 |
Trans-perineal implantation of radio-opaque treatment verification markers into the prostate: an assessment of procedure related morbidity, patient acceptability and accuracy
|
Henry, Ann M. |
|
2004 |
73 |
1 |
p. 57-59 3 p. |
artikel |